Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Prioritising children and adolescents in the tuberculosis response of the WHO European Region.

Gröschel MI, van den Boom M, Migliori GB, Dara M.

Eur Respir Rev. 2019 Mar 14;28(151). pii: 180106. doi: 10.1183/16000617.0106-2018. Print 2019 Mar 31. Review.

2.

Random glucose sampling as screening tool for diabetes among disadvantaged tuberculosis patients residing in urban slums in India.

Gröschel MI, Luz CF, Batra S, Ahuja S, Batra S, Kranzer K, van der Werf TS.

ERJ Open Res. 2019 Mar 11;5(1). pii: 00025-2019. doi: 10.1183/23120541.00025-2019. eCollection 2019 Feb.

3.

A Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence Setting.

Andres S, Gröschel MI, Hillemann D, Merker M, Niemann S, Kranzer K.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01798-18. doi: 10.1128/AAC.01798-18. Print 2019 Feb.

4.

Pathogen-based precision medicine for drug-resistant tuberculosis.

Gröschel MI, Walker TM, van der Werf TS, Lange C, Niemann S, Merker M.

PLoS Pathog. 2018 Oct 18;14(10):e1007297. doi: 10.1371/journal.ppat.1007297. eCollection 2018 Oct. No abstract available.

5.

Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis.

Lange C, Alghamdi WA, Al-Shaer MH, Brighenti S, Diacon AH, DiNardo AR, Grobbel HP, Gröschel MI, von Groote-Bidlingmaier F, Hauptmann M, Heyckendorf J, Köhler N, Kohl TA, Merker M, Niemann S, Peloquin CA, Reimann M, Schaible UE, Schaub D, Schleusener V, Thye T, Schön T.

J Intern Med. 2018 May 28. doi: 10.1111/joim.12780. [Epub ahead of print]

PMID:
29806961
6.

Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors.

Sayes F, Blanc C, Ates LS, Deboosere N, Orgeur M, Le Chevalier F, Gröschel MI, Frigui W, Song OR, Lo-Man R, Brossier F, Sougakoff W, Bottai D, Brodin P, Charneau P, Brosch R, Majlessi L.

Cell Rep. 2018 Apr 24;23(4):1072-1084. doi: 10.1016/j.celrep.2018.03.125.

7.

Non-Steroidal Anti-inflammatory Drugs As Host-Directed Therapy for Tuberculosis: A Systematic Review.

Kroesen VM, Gröschel MI, Martinson N, Zumla A, Maeurer M, van der Werf TS, Vilaplana C.

Front Immunol. 2017 Jun 30;8:772. doi: 10.3389/fimmu.2017.00772. eCollection 2017. Review.

8.

Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection.

Gröschel MI, Sayes F, Shin SJ, Frigui W, Pawlik A, Orgeur M, Canetti R, Honoré N, Simeone R, van der Werf TS, Bitter W, Cho SN, Majlessi L, Brosch R.

Cell Rep. 2017 Mar 14;18(11):2752-2765. doi: 10.1016/j.celrep.2017.02.057.

9.

ESX secretion systems: mycobacterial evolution to counter host immunity.

Gröschel MI, Sayes F, Simeone R, Majlessi L, Brosch R.

Nat Rev Microbiol. 2016 Nov;14(11):677-691. doi: 10.1038/nrmicro.2016.131. Epub 2016 Sep 26. Review.

PMID:
27665717
10.

CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection.

Sayes F, Pawlik A, Frigui W, Gröschel MI, Crommelynck S, Fayolle C, Cia F, Bancroft GJ, Bottai D, Leclerc C, Brosch R, Majlessi L.

PLoS Pathog. 2016 Jul 28;12(7):e1005770. doi: 10.1371/journal.ppat.1005770. eCollection 2016 Jul.

11.

Prolonged pyrexia and subtle skin lesions: polyarteritis nodosa.

Lai FYX, Gröschel MIP, van den Hende L, Diercks GFH, Rutgers A, van der Werf TS.

Lancet. 2016 Mar 5;387(10022):1025-1026. doi: 10.1016/S0140-6736(16)00501-8. Epub 2016 Mar 4. No abstract available.

PMID:
26972245
12.

Type VII Secretion Systems in Gram-Positive Bacteria.

Bottai D, Gröschel MI, Brosch R.

Curr Top Microbiol Immunol. 2017;404:235-265. doi: 10.1007/82_2015_5015. Review.

PMID:
26847354
13.

Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant Enterobacteriaceae.

Gröschel MI, Omansen TF, de Lange W, van der Werf TS, Lokate M, Bathoorn E, Akkerman OW, Stienstra Y.

Am J Trop Med Hyg. 2016 Mar;94(3):517-8. doi: 10.4269/ajtmh.15-0690. Epub 2016 Jan 11.

14.

Cytosolic access of Mycobacterium tuberculosis: critical impact of phagosomal acidification control and demonstration of occurrence in vivo.

Simeone R, Sayes F, Song O, Gröschel MI, Brodin P, Brosch R, Majlessi L.

PLoS Pathog. 2015 Feb 6;11(2):e1004650. doi: 10.1371/journal.ppat.1004650. eCollection 2015 Feb.

15.

Therapeutic vaccines for tuberculosis--a systematic review.

Gröschel MI, Prabowo SA, Cardona PJ, Stanford JL, van der Werf TS.

Vaccine. 2014 May 30;32(26):3162-8. doi: 10.1016/j.vaccine.2014.03.047. Epub 2014 Apr 13. Review.

PMID:
24726245
16.

Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines.

Prabowo SA, Gröschel MI, Schmidt ED, Skrahina A, Mihaescu T, Hastürk S, Mitrofanov R, Pimkina E, Visontai I, de Jong B, Stanford JL, Cardona PJ, Kaufmann SH, van der Werf TS.

Med Microbiol Immunol. 2013 Apr;202(2):95-104. doi: 10.1007/s00430-012-0278-6. Epub 2012 Nov 10. Review.

PMID:
23143437
17.

Immunology in tuberculosis: challenges in monitoring of disease activity and identifying correlates of protection.

van Altena R, Duggirala S, Gröschel MI, van der Werf TS.

Curr Pharm Des. 2011;17(27):2853-62. Review.

PMID:
21834760

Supplemental Content

Loading ...
Support Center